ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,039, issued on May 12, was assigned to DIZAL (JIANGSU) PHARCEUTICAL Co. LTD. (Shanghai).
"BTK inhibitors" was invented by Quan Zhou (Shanghai), Changmao Shen (Shanghai), Xiang Chen (Shanghai), Wengeng Liu (Shanghai), Rumin Wang (Shanghai), Qingbei Zeng (Shanghai), Honchung Tsui (Shanghai), Zhenfan Yang (Shanghai) and Xiaolin Zhang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof, of the formula (I) which possess BTK inhibitory activity and are accordingly useful in therapy and in methods of treatment of the human or animal body. The invention also relate...